0001415889-25-015039.txt : 20250530 0001415889-25-015039.hdr.sgml : 20250530 20250530175904 ACCESSION NUMBER: 0001415889-25-015039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250528 FILED AS OF DATE: 20250530 DATE AS OF CHANGE: 20250530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nanavaty Maulik CENTRAL INDEX KEY: 0001529708 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40672 FILM NUMBER: 251012541 MAIL ADDRESS: STREET 1: BOSTON SCIENTIFIC CORPORATION STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rani Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001856725 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2051 RINGWOOD AVENUE CITY: SAN JOSE STATE: CA ZIP: 95131 BUSINESS PHONE: (408) 457-3700 MAIL ADDRESS: STREET 1: 2051 RINGWOOD AVENUE CITY: SAN JOSE STATE: CA ZIP: 95131 4 1 form4-05302025_090545.xml X0508 4 2025-05-28 0001856725 Rani Therapeutics Holdings, Inc. RANI 0001529708 Nanavaty Maulik C/O RANI THERAPEUTICS LLC 2051 RINGWOOD AVE. SAN JOSE CA 95131 true false false false 0 Director Stock Option (Right to Buy) 0.62 2025-05-28 4 A 0 50000 0 A 2035-05-27 Class A Common Stock 50000 50000 D The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan). /s/ Svai Sanford, Attorney-in-Fact for Maulik Nanavaty 2025-05-30